Will EU countries be allowed to opt out of approved biotech crops?

After four years of uncertainty, an EU Commission proposal to permit individual countries to opt out of allowing the planting of biotech drops may be approved by the end of the year. According to a report by Inside U.S. Trade, Italian Agriculture Minister Maurizio Martina recently told the European Parliament the Italian presidency of the Council of the EU plans to begin negotiations with Parliament. Regardless of the outcomes of the talks, the EU policies on biotech crops will not become less controversial.

The EU Commission first made its proposal in July 2010 to permit countries to not allow the cultivation of EU-approved biotech crops. The reasoning was that by providing assurances that countries would not be required to allow planting of biotech crops, they would not oppose approvals for the rest of the EU. Many industry people and political watchers have questioned whether it is politically possible for an EU country official to vote for approval of a biotech crop at the EU level while opposing it for planting at home.

The U.S. Agricultural Attaches in the EU have identified a group of opposed countries (Austria, Croatia, Greece, Hungary, Italy, and Slovenia) that believe that biotech crop cultivation could not coexist with other types of agriculture. They would be dooming their agricultures to fall further and further behind the rest of the EU if others used biotech crops and they did not.

Read full, original article: Cultivating biotech crops in the EU

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.